The US Food and Drug Administration (FDA) has approved Interventional Spine's Opticage expandable intervertebral body fusion device.
Interventional said the Opticage Expandable Interbody forms an integral part of its PerX360 System.
Opticage provides surgeons the ability to perform a complete percutaneous lumbar interbody fusion via two 15mm incisions for the treatment of lumbar discogenic pain.
Flagler Brain and Spine Institute David Greenwald said because of this characteristic, the channel for insertion is reduced and will help minimize tissue trauma and decrease the patient overall recovery times.
Interventional Spine CEO Walter Cuevas said they now look forward to partner with surgeons in the US to make this technology available to them in a manner that will benefit their patients.